Production and characterization of monoclonal antibodies against the nucleocapsid protein of SARS-CoV

被引：0
|
作者：
Fang, Ying [1 ]
Pekosz, Andrew
Haynes, Lia
Nelson, Eric A.
Rowland, Raymond R. R.
机构：
[1] S Dakota State Univ, Brookings, SD 57007 USA
[2] Washington Univ, Sch Med, St Louis, MO 63130 USA
[3] Kansas State Univ, Manhattan, KS 66506 USA
[4] Ctr Dis Control & Prevent, Atlanta, GA USA
来源：
NIDOVIRUSES: TOWARD CONTROL OF SARS AND OTHER NIDOVIRUS DISEASES | 2006年 / 581卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：153 / 156
页数：4
相关论文
共 50 条
  • [21] Electrostatic features for nucleocapsid proteins of SARS-CoV and SARS-CoV-2
    Guo, Wenhan
    Xie, Yixin
    Lopez-Hernandez, Alan E.
    Sun, Shengjie
    Li, Lin
    MATHEMATICAL BIOSCIENCES AND ENGINEERING, 2021, 18 (03) : 2372 - 2383
  • [22] Production and Characterization of a SARS-CoV-2 Nucleocapsid Protein Reference Material
    Stocks, Bradley B.
    Thibeault, Marie-Pier
    L'Abbe, Denis
    Stuible, Matthew
    Durocher, Yves
    Melanson, Jeremy E.
    ACS MEASUREMENT SCIENCE AU, 2022, 2 (06): : 620 - 628
  • [23] Characterization of monoclonal antibodies directed against the canine distemper virus nucleocapsid protein
    Masuda, Munemitsu
    Sato, Hiroki
    Kamata, Hiroshi
    Katsuo, Tomoe
    Takenaka, Akiko
    Miura, Ryuichi
    Yoneda, Misako
    Tsukiyama-Kohara, Kyoko
    Mizumoto, Kiyohisa
    Kai, Chieko
    COMPARATIVE IMMUNOLOGY MICROBIOLOGY AND INFECTIOUS DISEASES, 2006, 29 (2-3) : 157 - 165
  • [24] Receptor-binding domain-specific human neutralizing monoclonal antibodies against SARS-CoV and SARS-CoV-2
    Yu, Fei
    Xiang, Rong
    Deng, Xiaoqian
    Wang, Lili
    Yu, Zhengsen
    Tian, Shijun
    Liang, Ruiying
    Li, Yanbai
    Ying, Tianlei
    Jiang, Shibo
    SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2020, 5 (01)
  • [25] Receptor-binding domain-specific human neutralizing monoclonal antibodies against SARS-CoV and SARS-CoV-2
    Fei Yu
    Rong Xiang
    Xiaoqian Deng
    Lili Wang
    Zhengsen Yu
    Shijun Tian
    Ruiying Liang
    Yanbai Li
    Tianlei Ying
    Shibo Jiang
    Signal Transduction and Targeted Therapy, 5
  • [26] Boosted expression of the SARS-CoV nucleocapsid protein in tobacco and its immunogenicity in mice
    Zheng, Nuoyan
    Xia, Ran
    Yang, Cuiping
    Yin, Bojiao
    Li, Yin
    Duan, Chengguo
    Liang, Liming
    Guo, Huishan
    Xie, Qi
    VACCINE, 2009, 27 (36) : 5001 - 5007
  • [27] Spike protein of SARS coronavirus (SARS-CoV) induces protective immunity against subsequent SARS-CoV challenge in mice
    Bisht, H
    Roberts, A
    Vogel, L
    Bukreyev, A
    Lamirande, E
    Collins, P
    Murphy, B
    Subbarao, K
    Moss, B
    FASEB JOURNAL, 2005, 19 (04): : A894 - A894
  • [28] The C-Terminal Portion of the Nucleocapsid Protein Demonstrates SARS-CoV Antigenicity
    Guozhen Liu
    Beijing Genomics Institute
    Wenzhou Medical College
    Molecular
    Genomics Proteomics & Bioinformatics, 2003, (03) : 193 - 197
  • [29] Monoclonal neutralizing antibodies against SARS-COV-2 S protein
    Cheng, Lin-Dong
    Li, Ping
    Lin, Yan-Chen
    Hu, Hui-Xiu
    Zhang, Ying
    Li, Hou-Feng
    Huang, Jing
    Tan, Li
    Ma, Ning
    Xia, Deng-Yun
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2024, 16 (02): : 681 - 689
  • [30] Identification of SARS-CoV RBD-targeting monoclonal antibodies with cross-reactive or neutralizing activity against SARS-CoV-2
    Tai, Wanbo
    Zhang, Xiujuan
    He, Yuxian
    Jiang, Shibo
    Du, Lanying
    ANTIVIRAL RESEARCH, 2020, 179
12345